Otorrhea Clinical Trial
| Verified date | January 2012 |
| Source | Alcon Research |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | United States: Food and Drug Administration |
| Study type | Observational |
This study was conducted to describe the time to first incidence of otorrhea post tympanostomy tube insertion.
| Status | Terminated |
| Enrollment | 1389 |
| Est. completion date | November 2011 |
| Est. primary completion date | November 2011 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 6 Months to 12 Years |
| Eligibility |
Inclusion Criteria: - Participants must be at least 6 months old and no more than 13 years of age at the time of enrollment scheduled for unilateral or bilateral myringotomy and tympanostomy tube insertion. Patients and/or child must read/sign informed consent and comply with requirement of the study. Exclusion Criteria: - There are no exclusion criteria. |
N/A
| Country | Name | City | State |
|---|---|---|---|
| United States | Contact Alcon Call Center for Trial Locations | Fort Worth | Texas |
| Lead Sponsor | Collaborator |
|---|---|
| Alcon Research |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Incidence of, time to, and relationship of risk factors associated with otorrhea post tympanostomy tube insertion. | Up to 1 year | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT03347461 -
Otiprio Versus Ciprodex Tympanostomy Tube Outcomes
|
Phase 4 | |
| Recruiting |
NCT04807660 -
Bacteriological Evaluation of Children With Otorrhea
|
||
| Withdrawn |
NCT00956748 -
N-Acetylcysteine as an Adjunct for Refractory Chronic Suppurative Otitis Media
|
Phase 4 | |
| Terminated |
NCT02817347 -
A Clinical Trial of YH1177 in Patients With Otitis Media and Otorrhea
|
Phase 1/Phase 2 |